Re-analysis of incurred plasma samples of one patient treated at the dose of 100 mg/m2 of PTX during the first chemotherapy cycle.

CORRESPONDENCE Troxacitabine in Patients With Refractory Leukemia

We Giles

October 2016

reporting the results of a phase II study of troxacitabine in patients with refractory leukemia. Alt...

(a) The clinical course of one of the studied patients who received three cycles of neoadjuvant paclitaxel (P) followed by four cycles of neoadjuvant doxorubicin with cyclophosphamide (AC) before surgery (Sx) and radiation therapy (Rxt)

Fernando LA Fonseca (96205)
Aleksandra VL Sant Ana (96206)
Israel Bendit (96207)
Vitor Arias (96208)
Luciano J Costa (96209)
Aparecida A Pinhal (96210)
Auro del Giglio (96211)

December 2011

Copyright information:Taken from "Systemic chemotherapy induces microsatellite inst...

Distribution of PTX3 levels in 704 AMI patients in relation to the time of blood collection.

Elisa Barbati (291668)
Claudia Specchia (291669)
Massimo Villella (291670)
Marco Luciano Rossi (291671)
Simona Barlera (291672)
Barbara Bottazzi (291673)
Luisa Crociati (291674)
Carmela d’Arienzo (291675)
Raffaele Fanelli (291676)
Cecilia Garlanda (291677)
Francesca Gori (291678)
Ruggiero Mango (266696)
Alberto Mantovani (287283)
Giuseppe Merla (124032)
Enrico B. Nicolis (291679)
Silvia Pietri (291680)
Patrizia Presbitero (291681)
Yukio Sudo (5988)
Alessandro Villella (291682)
Maria Grazia Franzosi (62722)

February 2013

Blood samples were collected from 5 to 733 days after the AMI. This range was divided into tertil...

Plasma concentration-vs-time profiles of PTX and its main metabolite 6α-OH-PTX in three patients with advanced ovarian cancer.

Bianca Posocco (692882)
Mauro Buzzo (4885432)
Andrea Follegot (4885429)
Luciana Giodini (4885435)
Roberto Sorio (811591)
Elena Marangon (692881)
Giuseppe Toffoli (56139)

February 2018

Patient 1, 2, and 3 received 110 mg/m2 of PTX as 1-h intravenous infusion during the f...

Representative SRM chromatograms.

Bianca Posocco (692882)
Mauro Buzzo (4885432)
Andrea Follegot (4885429)
Luciana Giodini (4885435)
Roberto Sorio (811591)
Elena Marangon (692881)
Giuseppe Toffoli (56139)

February 2018

(A): SRM chromatograms of a human blank plasma sample; (B): SRM chromatograms of a human blank pl...

Pharmacokinetic profiles before and after chemotherapy.

L. John Hoffer (717887)
Line Robitaille (717888)
Robert Zakarian (717889)
David Melnychuk (717890)
Petr Kavan (717891)
Jason Agulnik (717892)
Victor Cohen (717893)
David Small (640501)
Wilson H. Miller Jr. (217834)

April 2015

The data are presented as mean ± SD.* Moles of oxalic acid excreted per 100 mol of vitamin...

Serum level changes of BTMs during the chemotherapy process.

YangYang Chen (731784)
GuoBin Xu (731785)
Feng Yang (132135)

April 2015

Values were presented as mean± SD.*Statistically significant at P < 0.05.25(OH)D, 2...

Intra and inter-day precision and accuracy of the method for the analysis of PTX and its metabolite 6α-OH-PTX in human plasma samples.

Bianca Posocco (692882)
Mauro Buzzo (4885432)
Andrea Follegot (4885429)
Luciana Giodini (4885435)
Roberto Sorio (811591)
Elena Marangon (692881)
Giuseppe Toffoli (56139)

February 2018

Intra and inter-day precision and accuracy of the method for the analysis of PTX and its metaboli...

Platinum in Blood Mononuclear Cells from Patients after Cisplatin Therapy*f

F. William
Jonathan Sporn
Sidneym H O Pfer
Kevin R. Sw Eeney
Nitya G. Chakraborty
Bernard Greenberg

October 2016

The feasibility of monitoring cisplatin chemotherapy by measuring plati num (Pt) concentrations in b...

Drug regimens.

Sirin Yonucu (4442383)
Defne Yιlmaz (4442377)
Colin Phipps (4442380)
Mehmet Burcin Unlu (4442374)
Mohammad Kohandel (192746)

September 2017

From top to bottom, regimens for antiangiogenic agents alone (case-1), chemotherapy alone (case-2...

The plasma PQ concentrations of patients receiving repeated HP.

Yunying Shi (314946)
Yangjuan Bai (314947)
Yuangao Zou (314948)
Bei Cai (160529)
Fei Liu (21082)
Ping Fu (273326)
Lanlan Wang (160537)

February 2013

Note: C0–1 was the plasma PQ concentration prior to the first session of HP; C2–1...

The number of patients treated per cycle with the various chemotherapy agents and the number of patients evaluable for analysis of neutropenia.

Ira J. Dunkel (307425)
Weiji Shi (642843)
Kim Salvaggio (642844)
Brian P. Marr (307426)
Scott E. Brodie (307428)
Y. Pierre Gobin (307424)
David H. Abramson (307429)

October 2014

M: melphalan; T: topotecan; C: carboplatin.The number of patients treated per cycle with t...

Validation Trial of a Novel Marker of Delayed Chemotherapy-induced Emesis

Higa GM
Auber ML
Hobbs G

October 2016

Post hoc analyses of study data suggested that the ratio of substance P to 5-HIAA/creatinine was a n...

First-line chemotherapy regimens administered in the three groups of patients.

Alessandro Bittoni (316607)
Mario Scartozzi (316598)
Riccardo Giampieri (316608)
Luca Faloppi (316609)
Maristella Bianconi (316610)
Alessandra Mandolesi (316605)
Michela Del Prete (316614)
Mirco Pistelli (316606)
Luca Cecchini (453947)
Italo Bearzi (316626)
Stefano Cascinu (316628)

November 2013

First-line chemotherapy regimens administered in the three groups of patients.</p

Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients

Rottey, Sylvie
VAN DEN BOSSCHE, BIEKE
Slegers, G
Van Belle, Simon
Van De Wiele, Christophe

January 2009

Aim. The aim of this study was to determine whether administration of chemotherapy interferes with t...

CORRESPONDENCE Troxacitabine in Patients With Refractory Leukemia

We Giles

October 2016

reporting the results of a phase II study of troxacitabine in patients with refractory leukemia. Alt...

(a) The clinical course of one of the studied patients who received three cycles of neoadjuvant paclitaxel (P) followed by four cycles of neoadjuvant doxorubicin with cyclophosphamide (AC) before surgery (Sx) and radiation therapy (Rxt)

Fernando LA Fonseca (96205)
Aleksandra VL Sant Ana (96206)
Israel Bendit (96207)
Vitor Arias (96208)
Luciano J Costa (96209)
Aparecida A Pinhal (96210)
Auro del Giglio (96211)

December 2011

Copyright information:Taken from "Systemic chemotherapy induces microsatellite inst...

Distribution of PTX3 levels in 704 AMI patients in relation to the time of blood collection.

Elisa Barbati (291668)
Claudia Specchia (291669)
Massimo Villella (291670)
Marco Luciano Rossi (291671)
Simona Barlera (291672)
Barbara Bottazzi (291673)
Luisa Crociati (291674)
Carmela d’Arienzo (291675)
Raffaele Fanelli (291676)
Cecilia Garlanda (291677)
Francesca Gori (291678)
Ruggiero Mango (266696)
Alberto Mantovani (287283)
Giuseppe Merla (124032)
Enrico B. Nicolis (291679)
Silvia Pietri (291680)
Patrizia Presbitero (291681)
Yukio Sudo (5988)
Alessandro Villella (291682)
Maria Grazia Franzosi (62722)

February 2013

Blood samples were collected from 5 to 733 days after the AMI. This range was divided into tertil...

Plasma concentration-vs-time profiles of PTX and its main metabolite 6α-OH-PTX in three patients with advanced ovarian cancer.

Bianca Posocco (692882)
Mauro Buzzo (4885432)
Andrea Follegot (4885429)
Luciana Giodini (4885435)
Roberto Sorio (811591)
Elena Marangon (692881)
Giuseppe Toffoli (56139)

February 2018

Patient 1, 2, and 3 received 110 mg/m2 of PTX as 1-h intravenous infusion during the f...

Representative SRM chromatograms.

Bianca Posocco (692882)
Mauro Buzzo (4885432)
Andrea Follegot (4885429)
Luciana Giodini (4885435)
Roberto Sorio (811591)
Elena Marangon (692881)
Giuseppe Toffoli (56139)

February 2018

(A): SRM chromatograms of a human blank plasma sample; (B): SRM chromatograms of a human blank pl...

Pharmacokinetic profiles before and after chemotherapy.

L. John Hoffer (717887)
Line Robitaille (717888)
Robert Zakarian (717889)
David Melnychuk (717890)
Petr Kavan (717891)
Jason Agulnik (717892)
Victor Cohen (717893)
David Small (640501)
Wilson H. Miller Jr. (217834)

April 2015

The data are presented as mean ± SD.* Moles of oxalic acid excreted per 100 mol of vitamin...

Serum level changes of BTMs during the chemotherapy process.

YangYang Chen (731784)
GuoBin Xu (731785)
Feng Yang (132135)

April 2015

Values were presented as mean± SD.*Statistically significant at P < 0.05.25(OH)D, 2...

Intra and inter-day precision and accuracy of the method for the analysis of PTX and its metabolite 6α-OH-PTX in human plasma samples.

Bianca Posocco (692882)
Mauro Buzzo (4885432)
Andrea Follegot (4885429)
Luciana Giodini (4885435)
Roberto Sorio (811591)
Elena Marangon (692881)
Giuseppe Toffoli (56139)

February 2018

Intra and inter-day precision and accuracy of the method for the analysis of PTX and its metaboli...

Platinum in Blood Mononuclear Cells from Patients after Cisplatin Therapy*f

F. William
Jonathan Sporn
Sidneym H O Pfer
Kevin R. Sw Eeney
Nitya G. Chakraborty
Bernard Greenberg

October 2016

The feasibility of monitoring cisplatin chemotherapy by measuring plati num (Pt) concentrations in b...

Drug regimens.

Sirin Yonucu (4442383)
Defne Yιlmaz (4442377)
Colin Phipps (4442380)
Mehmet Burcin Unlu (4442374)
Mohammad Kohandel (192746)

September 2017

From top to bottom, regimens for antiangiogenic agents alone (case-1), chemotherapy alone (case-2...

The plasma PQ concentrations of patients receiving repeated HP.

Yunying Shi (314946)
Yangjuan Bai (314947)
Yuangao Zou (314948)
Bei Cai (160529)
Fei Liu (21082)
Ping Fu (273326)
Lanlan Wang (160537)

February 2013

Note: C0–1 was the plasma PQ concentration prior to the first session of HP; C2–1...

The number of patients treated per cycle with the various chemotherapy agents and the number of patients evaluable for analysis of neutropenia.

Ira J. Dunkel (307425)
Weiji Shi (642843)
Kim Salvaggio (642844)
Brian P. Marr (307426)
Scott E. Brodie (307428)
Y. Pierre Gobin (307424)
David H. Abramson (307429)

October 2014

M: melphalan; T: topotecan; C: carboplatin.The number of patients treated per cycle with t...

Validation Trial of a Novel Marker of Delayed Chemotherapy-induced Emesis

Higa GM
Auber ML
Hobbs G

October 2016

Post hoc analyses of study data suggested that the ratio of substance P to 5-HIAA/creatinine was a n...

First-line chemotherapy regimens administered in the three groups of patients.

Alessandro Bittoni (316607)
Mario Scartozzi (316598)
Riccardo Giampieri (316608)
Luca Faloppi (316609)
Maristella Bianconi (316610)
Alessandra Mandolesi (316605)
Michela Del Prete (316614)
Mirco Pistelli (316606)
Luca Cecchini (453947)
Italo Bearzi (316626)
Stefano Cascinu (316628)

November 2013

First-line chemotherapy regimens administered in the three groups of patients.</p

Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients

Rottey, Sylvie
VAN DEN BOSSCHE, BIEKE
Slegers, G
Van Belle, Simon
Van De Wiele, Christophe

January 2009

Aim. The aim of this study was to determine whether administration of chemotherapy interferes with t...

CORRESPONDENCE Troxacitabine in Patients With Refractory Leukemia

We Giles

October 2016

reporting the results of a phase II study of troxacitabine in patients with refractory leukemia. Alt...

(a) The clinical course of one of the studied patients who received three cycles of neoadjuvant paclitaxel (P) followed by four cycles of neoadjuvant doxorubicin with cyclophosphamide (AC) before surgery (Sx) and radiation therapy (Rxt)

Fernando LA Fonseca (96205)
Aleksandra VL Sant Ana (96206)
Israel Bendit (96207)
Vitor Arias (96208)
Luciano J Costa (96209)
Aparecida A Pinhal (96210)
Auro del Giglio (96211)

December 2011

Copyright information:Taken from "Systemic chemotherapy induces microsatellite inst...

Distribution of PTX3 levels in 704 AMI patients in relation to the time of blood collection.

Elisa Barbati (291668)
Claudia Specchia (291669)
Massimo Villella (291670)
Marco Luciano Rossi (291671)
Simona Barlera (291672)
Barbara Bottazzi (291673)
Luisa Crociati (291674)
Carmela d’Arienzo (291675)
Raffaele Fanelli (291676)
Cecilia Garlanda (291677)
Francesca Gori (291678)
Ruggiero Mango (266696)
Alberto Mantovani (287283)
Giuseppe Merla (124032)
Enrico B. Nicolis (291679)
Silvia Pietri (291680)
Patrizia Presbitero (291681)
Yukio Sudo (5988)
Alessandro Villella (291682)
Maria Grazia Franzosi (62722)

February 2013

Blood samples were collected from 5 to 733 days after the AMI. This range was divided into tertil...

Re-analysis of incurred plasma samples of one patient treated at the dose of 100 mg/m<sup>2</sup> of PTX during the first chemotherapy cycle.

Abstract

Extracted data

Re-analysis of incurred plasma samples of one patient treated at the dose of 100 mg/m<sup>2</sup> of PTX during the first chemotherapy cycle.

Abstract

Extracted data

Related items

Related items